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Gassericin A, produced by Lactobacillus gasseri LA39, is a hydrophobic circular bacteriocin. The DNA region
surrounding the gassericin A structural gene, gaaA, was sequenced, and seven open reading frames (ORFs) of
3.5 kbp (gaaBCADITE) were found with possible functions in gassericin A production, secretion, and immunity.
The deduced products of the five consecutive ORFs gaaADITE have homology to those of genes involved in
butyrivibriocin AR10 production, although the genetic arrangements are different in the two circular bacteri-
ocin genes. GaaI is a small, positively charged hydrophobic peptide of 53 amino acids containing a putative
transmembrane segment. Heterologous expression and homologous expression of GaaI in Lactococcus lactis
subsp. cremoris MG1363 and L. gasseri JCM1131T, respectively, were studied. GaaI-expressing strains exhib-
ited at least sevenfold-higher resistance to gassericin A than corresponding control strains, indicating that gaaI
encodes an immunity peptide for gassericin A. Comparison of GaaI to peptides with similar characteristics
found in the circular bacteriocin gene loci is discussed.
Bacteriocins are antimicrobial peptides that act primarily
against related bacterial species. The classification of bacterio-
cins remains controversial. Here, we use the classification of
Maqueda et al. (30): class I (lantibiotics); class II (nonlantibi-
otics) with subclasses IIa (antilisteral pediocin-like bacterio-
cins), IIb (two-peptide bacteriocins), and IIc (leaderless bac-
teriocins); class III (large heat-labile bacteriocins); and class
IV (circular bacteriocins linked at the N- and C-terminal
amino acids).
Nine class IV circular bacteriocins have been reported to
date. They can be further divided into two major groups by
using their primary structures, biochemical characteristics, and
genetic arrangements. One group is the family of enterocin
AS-48 (32), the first circular bacteriocin described (in 1994),
which includes circularin A (25) and uberolysin (40). The other
group is the family of gassericin A (19, 21), the second bacte-
riocin found (in 1998), which includes acidocin B (28), reuteri-
cin 6 (with a primary structure 100% identical to that of gas-
sericin A) (22, 23), butyrivibriocin AR10 (17), and carnocyclin
A, from Carnobacterium maltaromaticum UAL307 (33). The
lantibiotic-like subtilosin A produced by Bacillus subtilis subsp.
subtilis strain 168 (24) is an orphan member of the class IV
bacteriocins. The gassericin A family of bacteriocins have been
isolated from various bacterial species in several countries,
suggesting the bacteriocin genes may be associated with trans-
ferable genetic elements.
The bacteriocins of lactic acid bacteria (LAB) and bacteri-
ocin-producing LAB strains isolated from foods are promising
food preservative candidates, and strains of human origin are
expected to be probiotics that could help to prevent the growth
of harmful bacteria in food and the human intestine. Lactoba-
cillus gasseri belongs to the Lactobacillus acidophilus group of
LAB, which are natural inhabitants of the human intestinal
tract (35), and many L. gasseri strains have been shown to
produce bacteriocins (16, 20). Gassericin A was produced by L.
gasseri LA39 isolated from the feces of a human infant; it has
bactericidal activity against the food-borne pathogens Listeria
monocytogenes, Bacillus cereus, and Staphylococcus aureus (16).
Recently, using proteose peptone, some strains of L. gasseri
containing LA39 were successfully cultured in reconstituted
skim milk and cheese whey, where L. gasseri LA39 produced
gassericin A; these low-cost, safe media could be used to im-
prove the safety of biopreservation (1). Gassericin A has been
purified and characterized, and its structural gene (gaaA) has
been cloned and sequenced (21, 22). Determination of the
complete chemical structure of gassericin A showed that the
bacteriocin belongs to class IV and consists of 58 amino acid
residues linked at the N and C termini (19). Little is known
about the mechanisms of secretion and circularization of gas-
sericin A and immunity to the circular bacteriocin.
Here, we sequenced six genes surrounding gaaA thought to
be related to production of and immunity to gassericin A and
examined the homologous and heterologous expression of a
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small hydrophobic peptide, GaaI; we found that gaaI is an
immunity gene providing protection against gassericin A.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The strains and plasmids used in this
study are listed in Table 1. The gassericin A producer, L. gasseri LA39
(JCM11657), isolated in our laboratory from the feces of a 4-month-old infant
(23), and the non-bacteriocin producer L. gasseri JCM1131T (ATCC 33323T) (2)
were grown at 37°C in MRS broth (Difco Laboratories, Detroit, MI). M17 broth
(Difco) with 0.5% (wt/vol) glucose (GM17) was used for the cultures of Lacto-
coccus lactis subsp. cremoris MG1363 at 30°C and Enterococcus faecalis JH2-2 at
37°C. Escherichia coli DH5 was cultured for 16 h in tryptone-yeast broth with
vigorous agitation (250 rpm) at 37°C. Broth agar and soft-agar media contained
1.5% (wt/vol) and 0.7% (wt/vol) agar (agar no. 1; Oxoid Ltd., Basingstoke,
Hampshire, United Kingdom), respectively. To select and maintain transfor-
mants, ampicillin (Sigma, Zwijndrecht, The Netherlands) was used at 100 g/ml
for E. coli and erythromycin (Sigma) was used at 5 g/ml for L. gasseri, L. lactis
subsp. cremoris, and E. faecalis.
Nucleotide sequencing. The nucleotide sequence surrounding gaaA was de-
termined by primer walking using the total DNA of L. gasseri LA39 as the
template. PCR fragments were purified using the High Pure PCR product pu-
rification kit (Roche Diagnostics GmbH, Mannheim, Germany) and were se-
quenced either directly or after being subcloned into pCR2.1-TOPO. DNA
sequencing was performed using the dideoxy chain termination method with a
Prism 3100 Genetic Analyzer (Applied Biosystems Japan Ltd., Tokyo, Japan)
and a BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems Japan
Ltd.) or using T7 primers with the AlfII system (Amersham Pharmacia Biotech)
according to the protocols of the manufacturers.
Computational analyses. Open reading frames (ORFs) were identified using
the Glimmer 2.0 program (6) and/or GENETYX-MAC software (Software De-
velopment, Tokyo, Japan). Homology searches were performed using the
BLAST program (http://blast.ddbj.nig.ac.jp/top-j.html) in the DDBJ databases.
Transmembrane regions in peptides were deduced using the SOSUI program
(http://bp.nuap.nagoya-u.ac.jp/sosui/) (13).
Cloning methods and materials. Molecular cloning techniques were per-
formed essentially as described by Sambrook et al. (36). The restriction enzymes,
T4 DNA ligase and Expand DNA polymerase, were obtained from Roche Di-
agnostics GmbH and used as described by the manufacturer. Plasmid DNA was
introduced into L. lactis subsp. cremoris MG1363 and L. gasseri JCM1131T using
the electroporation methods described by Holo and Nes (14) and Luchansky et
al. (29), respectively. E. faecalis JH2-2 was grown in the presence of 8% (wt/vol)
glycine to prepare electrocompetent cells (http://www.enterococcus.ouhsc.edu
/electroporation.asp) (37). After transformation, L. lactis subsp. cremoris
MG1363 and E. faecalis JH2-2 were inoculated onto GM17 agar containing 0.5
M sucrose and erythromycin, and L. gasseri JCM1131T was inoculated onto MRS
agar containing erythromycin. Plasmids from these strains were prepared accord-
ing to the method of Birnboim and Doly (3).
Cloning of the hetero- and homodeterminants carrying the immunity peptide
for gassericin A. The gaaI region was amplified using Expand DNA polymerase
with the primers 5-ACGCGTCGACTTGTGCAGTACGTTATTTAAG-3 and
5-GCTCTAGACATCTACCCTTTATCCTTTGTTAC-3. The SalI and XbaI
sites are underlined in the primer sequences. The PCR product was cloned into
pCR2.1-TOPO with the Topo TA cloning kit (Invitrogen, Breda, The Nether-
lands) to create pCR2.1-LG45 using E. coli DH5. After digestion of pCR2.1-
LG45 with SalI and XbaI, the gaaI fragment was ligated into pIL253-P32 di-
gested with the same enzymes. The ligation mixture was used to transform E.
faecalis JH2-2. The resultant plasmid, designated pGAI, was introduced into L.
lactis subsp. cremoris MG1363 and L. gasseri JCM1131T.
Bacteriocin tolerance assay. Bacteriocin tolerance was assayed using the agar
well diffusion method. Briefly, the MRS culture supernatant of L. gasseri LA39
containing gassericin A and the gassericin A purified as described previously
(23), were mixed with 50 mM sterile sodium phosphate buffer (pH 6.8) and 60%
(vol/vol) 2-propanol, respectively, and then serially diluted as 1/n (n represents
integrals from 1 to 32). Appropriate broth agar plates (4 mm thick and 90 mm in
diameter) were overlaid with a soft-agar lawn (10 ml) inoculated with a diluted
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Descriptiona Reference or source
Strains
L. gasseri
LA39 Gassericin A producer  JCM11657 Laboratory collection
JCM1131T Bacteriocin indicator  ATCC 33323T JCMb
E. faecalis JH2-2 Plasmid-free derivative of E. faecalis JH-2 17
L. lactis subsp. cremoris MG1363 Plasmid-free derivative of NCDO712 11
E. coli DH5 Plasmid free 12
Plasmids
pIL253-P32 Emr; pIL253 derivative with P32 promoter 26
pCR2.1-TOPO Ampr Kmr Invitrogen
pCR2.1-LG45 Ampr Kmr This study
pGAI Emr; pIL253-P32 derivative carrying gaaI This study
a Ampr, ampicillin resistance; Emr, erythromycin resistance; Kmr, kanamycin resistance.
b JCM, Japan Collection of Microorganisms.
TABLE 2. Deduced peptides and proteins derived from gaa
ORF Length(amino acids) MW pI Function Best homolog [identities (no. of amino acids, %)]
Localization
(TMS no.)a
gaaB 174 20,278 9.6 Unknown Acidocin B: unnamed protein product (101/103, 98) Membrane (5)
gaaC 60 7,291 9.6 Unknown Acidocin B: unnamed protein product (60/60, 100) Membrane (2)
gaaA 91 9,285 9.4 Gassericin A precursor Acidocin B: bacteriocin (89/91, 98) Membrane (2)
gaaD 162 18,344 6.9 Unknown Acidocin B: unnamed protein product (111/113, 98) Membrane (4)
gaaI 53 6,135 11.1 Immunty peptide No hit Membrane (1)
gaaT 226 25,126 4.7 ATP-binding protein Transporter Clostridium tetani E88 (77/212, 36;
positives, 131/212, 61)
Soluble (none)
gaaE 212 23,665 9.5 Accessory protein ABC-type transport system Clostridium difficile
QCD-32g58 (53/214, 24; positives, 111/214, 51)
Membrane (6)
a Deduced using the SOSUI program.
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overnight culture of each of the indicator strains at 1% (vol/vol). Wells (5 mm in
diameter) were cut from the plates, and 65 l of the serially diluted bacteriocin
sample was added to each well. The minimum inhibitory dilution of the bacte-
riocin against the indicator strains was measured to determine the relative
resistance to gassericin A. The experiments were performed in triplicate.
Nucleotide sequence accession number. The 4,100-bp DNA sequence contain-
ing the seven gaa genes is deposited in the DDBJ, EMBL, and GenBank data-
bases under accession number AB007043.
RESULTS AND DISCUSSION
The nucleotide sequence of an approximately 20-kbp region
surrounding the structural gene of gassericin A, gaaA, was
sequenced by primer walking using the total DNA of L. gasseri
LA39. Using computer analyses, seven ORFs, including gaaA,
putatively related to gassericin A production were deduced in
a 3.5-kbp region and designated gaaBCADITE (Table 2 and
Fig. 1). ORFs outside of the 3.5-kbp region did not show
similarity to known bacteriocin-related genes. gaaI encodes a
peptide of 53 amino acid residues. Expression studies have
shown that GaaI is an immunity peptide (described below).
GaaT contains an ABC transporter nucleotide-binding domain
(cd00267 ABC_ATPase) and is homologous to the putative
ABC transporter ATP-binding proteins found in several spe-
cies of Clostridium and Bacillus. GaaE is a putative membrane
protein with six transmembrane regions and shows similarity to
several proteins annotated as putative permeases. gaaT and
gaaE may encode the exporter of gassericin A during its pro-
duction process and/or may function as the auxiliary immunity
mechanism, as is observed in several bacteriocin genes, such as
the enterocin AS-48 gene (7, 31). gaaB, gaaC, and gaaD may be
membrane associated, but we were unable to speculate about
their functions using the bioinformatics approach. Potential
promoter sequences were predicted in the gaa region (Fig. 1).
Interestingly, most of the putative promoters are located
within the coding regions of the gaa genes. Terminators were
predicted downstream of gaaA and gaaE (Fig. 1) with G
values of 	15.8 kcal and 	9.0 kcal, respectively, but this was
not determined for the other gaa genes.
Some of the seven gaa genes are similar to other circular-
bacteriocin genes, especially to the acidocin B genes from L.
acidophilus M46 (28) and the butyrivibriocin AR10 genes from
the ruminal bacterium Butyrivibrio fibrisolvens AR10 (14) (Fig.
1). The closest comparison is to the acidocin B gene locus
(acd), where approximately 2 kb of the reported 2,200-bp se-
quence of the acd locus is 98.4% identical to gaa (Fig. 1). gaaC
and gaaA are almost identical to ORF1 and acdB in the acd
locus, respectively. ORF3 of acd may be a truncation of gaaD.
An ORF encoding 103 amino acids but unassigned in the
reference was found upstream of acd ORF1 (Fig. 1). The newly
identified ORF lacks a ribosome binding site but shows 98%
amino acid identity to the C terminus of GaaB. Further, three
fragmented traces of gaaI are found in the acd sequence. These
ORF truncations in acd are caused by a number of frameshifts.
The gaa region showed lower DNA homology but still signif-
icant genetic similarity to the putative circular butyrivibriocin
FIG. 1. Comparison of the gaa, acd, and bvi loci. The protein names and identified or proposed functions are shown. The structural genes gaaA,
acdB, and bviA are represented by black arrows; the immunity genes gaaI and bviE are represented by hatched arrows; the transport genes gaaT,
gaaE, bviB, bviC, and bviD are represented by shaded arrows; and the regulation genes of ORF1 and ORF2 in bvi are represented by horizontally
striped arrows. The open boxes in gaa and acd indicate that the regions are 98.4% identical. Predicted promoters and terminators are represented
by angled arrows and omega-like symbols, respectively.
FIG. 2. Plasmid map of the gaaI expression vector pGAI. P32, the
lactococcal constitutive promoter (39); gaaI, the putative gassericin A
immunity gene; emr, the erythromycin resistance gene; ORF3, an un-
characterized ORF in the vector pIL253; and repE, the replication
protein E gene.
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AR10 locus (bvi) from B. fibrisolvens AR10 (18) (Fig. 1). gaaA
is 57.5% similar to bviA (the structural gene of butyrivibriocin
AR10). gaaT and gaaE are 52.2% and 52.4% similar to bviB
and bviC, respectively, although the two putative transporter
genes of bvi reside upstream of bviA (Fig. 1). BviE, a putative
immunity protein (18), shows low amino acid sequence simi-
larity to GaaD. We did not find genes corresponding to the
putative two-component regulator genes (ORF1, encoding a
response regulator-like protein, and ORF2, encoding a histi-
dine kinase-like protein), bviD (encoding a putative trans-
porter element or immunity peptide), and ORF8 in the bvi
locus detected in the 20-kbp sequence of LA39, while genes
like gaaB and gaaC were not present in the reported bvi se-
quence. The production of several bacteriocins is regulated by
pheromones (inducer peptides) and two-component regulator
systems that respond to the pheromone (4, 9, 27). LA39 pro-
duces gassericin A constitutively when grown in MRS or milk-
based media under various pH conditions (unpublished re-
sults). The lack of genes for a response regulator and sensor
histidine kinase in the gaa locus may explain the observed
nonregulated expression of gassericin A.
We studied the possibility that GaaI is the gassericin A
immunity peptide. gaaI was cloned downstream of the lacto-
coccal P32 promoter in pIL253-P32, and the heterologous ex-
pression and homologous expression of GaaI from the result-
ing plasmid, pGAI (Fig. 2), were examined in L. lactis subsp.
cremoris MG1363 and L. gasseri JCM1131T, respectively. Al-
though the growth of L. lactis subsp. cremoris MG1363 was
completely inhibited by 60% (vol/vol) 2-propanol to dissolve
FIG. 3. Primary sequences of (putative) immunity peptides of circular bacteriocins. GaaI, BviD (putative; although BviD does not show
homology to GaaI, the two peptides are the same length at 53 amino acid residues), As-48D1, CirE, UblE (putative), and AblB are the immunity
peptides for gassericin A, butyrivibriocin AR10, enterocin AS-48, circularin A, uberolysin, and subtilosin A, respectively. The transmembrane
regions deduced using the SOSUI program are underlined. The residue positions and lengths of the regions are shown within parentheses.
Positively charged amino acid residues (lysine and arginine) outside of the TMSs are shaded.
TABLE 3. Minimum inhibitory dilutions for the MRS culture
supernatant of L. gasseri LA39 and purified gassericin A
against the constructed strains
Tested strain













a 	, not inhibited; IP, inhibited by 60% (vol/vol) 2-propanol.
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the hydrophobic purified gassericin A for the bacteriocin tol-
erance assay, both recombinant strains were at least seven
times more resistant to the purified gassericin A and the MRS
broth culture supernatants of L. gasseri LA39 than the respec-
tive control strains carrying pIL253-P32 (Table 3). This indi-
cates that gaaI encodes an immunity peptide for gassericin A.
As shown above, the sequenced region of the acd locus is
highly similar to that of gaa. However, the supposed homolog
FIG. 4. Hydropathy of (putative) immunity peptides and cognate circular bacteriocins. Hydrophilic and hydrophobic regions were deduced using GENE-
TYX-MAC software (Hoop and Woods [15]). The x axis shows the amino acid residue positions of the peptides, and the y axis is the hydropathy index.
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of gaaI in the acd sequence may be completely disrupted (Fig.
1). This is unexpected, because gaaI may be the immunity
determinant of gaa. If the acd cluster extended downstream of
the reported sequence and contained homologs of gaaT and
gaaE, these regions might constitute the primary resistance
mechanism and would likely be the active export mechanism of
acidocin B.
Usually bacteriocin producers also synthesize a protein(s) or
peptide(s) to protect themselves from the actions of their own
bacteriocins. ABC transporters, often with so-called accessory
proteins, transport a cognate bacteriocin(s) and provide resis-
tance by pumping out (active export) the bacteriocin molecules
that have invaded from outside of the producing cells (4, 7).
Many bacteriocin producers also make specific immunity pro-
teins (peptides) to counteract the activity of the bacteriocin
they produce. Generally, immunity proteins (peptides) are di-
verse in their primary structures (10, 34). Several small pep-
tides, such as GaaI, have been implicated in providing immu-
nity to circular bacteriocins (described below). Figure 3 shows
the primary sequence and deduced transmembrane regions of
the small immunity peptides for the class IV circular bacterio-
cins. The peptides, GaaI, BviD, As-48D1 (for enterocin AS-
48), CirE (for circularin A), and AblB (for subtilosin A), rang-
ing in size from 49 to 56 amino acid residues, have one or two
transmembrane segments (TMSs), except for UblE (three
TMSs), the putative immunity peptide for uberolysin, which
consists of 89 amino acid residues and is slightly longer than
the immunity peptides of other class IV bacteriocins (30).
These TMSs may expose positively charged amino acid resi-
dues to the outer surface of the cytoplasmic membrane. These
predictions suggest that the immunity peptides for class IV
bacteriocins may be located in the cell membranes of the
producing strains. As seen in Fig. 3, these peptides contain
several lysines and arginines outside of the putative TMSs.
This suggests that these positively charged residues on the
peptides located on the outer and/or inner surface of the cell
membrane may electrostatically prevent the attachment of cog-
nate bacteriocins that are also positively charged. Conversely,
many immunity proteins of the class IIa bacteriocins, ranging
in size from 81 to 115 amino acid residues, which have been
classified into three groups according to sequence homology
(leucocin A and enterocin A in group A, piscicolin 126 and
sakacin P in group B, and carnobacteriocin B2 and enterocin P
in group C) (10), have no deduced TMSs and may be located
at the inner surface of the cell membrane and act intracellu-
larly (6, 10, 34). The mechanism of immunity peptides working
against class IV bacteriocins could be different from that of
immunity peptides of class IIa bacteriocins (8, 34, 38), as the
modes of action of the two classes of bacteriocins may be
different.
Figure 4 shows the hydrophobicity/hydrophilicity of the im-
munity peptides and the class IV bacteriocins predicted using
the GENETYX-MAC software (Hoop and Woods [15]). The
N and C termini and the middle region in the immunity pep-
tides are hydrophilic and/or neutral, and the height of the
hydrophilicity and the depth of the hydrophobicity are more
than those of corresponding bacteriocins, except for AS-48.
The orientation of hydrophobicity has nearby symmetry on a
vertical line at the center of the peptides in spite of the differ-
ent numbers of -helical transmembrane regions (Fig. 3). This
suggests that the immunity function works on the inner and
outer cytoplasmic membranes against the compact globular
class IV bacteriocins that are considered to invade on the
intracellular side of the producing strains. We will require
further study to unravel the intricacies in the mode of action
and protection against the circular bacteriocins.
We attempted to produce gassericin A using the expression
vector pIL253-P32 and gaa genes identified in this study. How-
ever, cloning of all seven gaa genes into pIL253-P32 was not
successful in either L. lactis subsp. cremoris or L. gasseri hosts.
No transformants of L. gasseri JCM1131T were obtained with a
pIL253-P32-based plasmid carrying the six consecutive ORFs
gaaCADITE constructed in L. lactis subsp. cremoris MG1363.
The five consecutive ORFs gaaADITE could be cloned in
pIL253-P32 and introduced into L. gasseri JCM1131T; how-
ever, no bacteriocin activity was detected in the culture super-
natants of the recombinant strains (data not shown). Recently,
an experiment to clone the seven gaa genes into another vector
to express active gassericin A succeeded (data not shown).
These results indicate that gaaB and/or gaaC with each pro-
moter may be involved in the expression of active gassericin A.
Further analysis and characterization of the expressed gasse-
ricin A from L. gasseri JCM1131T are in progress. Although the
nearly 100 naturally occurring circular proteins and peptides
have been found in bacteria, plants, and animals, except for
humans, and the circular structure is usually involved to pro-
vide stability against pH, heat, and proteolytic degradation, the
cyclization mechanism for the involved enzymes and their aux-
iliary proteins remains to be elucidated (5). Circular bacterio-
cins, such as gassericin A and AS-48, of which the linear pre-
cursor peptide is encoded by one gene, should be good
candidates for analysis of those seamless peptides.
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